Title: Section 58-5.1 - Definitions

Effective Date

10/13/1999

58-5.1 Definitions. As used in this Part:

(a) Bone marrow means the human tissue filling cavities of bone, consisting of fully mature and precursor hematopoietic cells intended for transplantation.

(b) Hematopoietic progenitor cells means human precursor hematopoietic cells derived from bone marrow, peripheral blood or other tissue sources, such as cord blood obtained from the placenta or umbilical cord. (c) Hematopoietic progenitor cell bank means hematopoietic progenitor cell procurement service, hematopoietic progenitor cell processing facility or hematopoietic progenitor cell transplantation facility.

(d) Hematopoietic progenitor cell procurement service means a facility which performs donor selection and bone marrow aspiration or other hematopoietic progenitor cell collection, and pre-processing storage of hematopoietic progenitor cells from autogeneic and/or allogeneic donors.

(e) Hematopoietic progenitor cell processing facility means a facility which processes bone marrow or other hematopoietic progenitor cell samples, including purging, storage, and distribution of hematopoietic progenitor cells from autogeneic and/or allogeneic donors. (f) Hematopoietic progenitor cell transplantation facility means a facility which temporarily stores and transplants hematopoietic progenitor cells, and includes facilities which infuse autogeneic hematopoietic progenitor cells and bone marrow transplantation services approved by the commissioner pursuant to section 709.8 of this Title. (g) Hematopoietic progenitor cell transplantation service means a specific unit conducting hematopoietic progenitor cell transplantation within a hematopoietic progenitor cell transplantation facility. Such a service shall be independently supervised by a qualified director.

(h) Department means the New York State Department of Health. (i) Commissioner means the Commissioner of the New York State Department of Health.

Volume

VOLUME A-1 (Title 10)

up